Novartis Set to Acquire Mariana Oncology to Enhance Radioligand Therapy Pipeline
Deal includes a number of radioligand therapies targeting solid tumors, such as breast, prostate, and lung cancers.
October 26, 2026
Deal includes a number of radioligand therapies targeting solid tumors, such as breast, prostate, and lung cancers.